The histology and cytology market has seen considerable growth due to a variety of factors.
• The histology and cytology market has expanded rapidly in recent years. It will rise from $17.12 billion in 2024 to $19.26 billion in 2025, reflecting a compound annual growth rate (CAGR) of 12.5%.
The growth seen during the historical period is driven by the high prevalence of chronic diseases, rising healthcare spending, technological advancements in imaging, an increase in research activities, and an aging global population.
The histology and cytology market is expected to maintain its strong growth trajectory in upcoming years.
• The histology and cytology market is projected to reach $30.5 billion by 2029, growing at a CAGR of 12.2%.
Growth drivers include the rising prevalence of cancer, demand for personalized medicine, healthcare infrastructure expansion in emerging markets, imaging technique innovations, aging population, and increased R&D in life sciences. Trends include automation, digital pathology adoption, personalized medicine growth, tissue staining technology advancements, oncology research, workflow efficiency, and lab infrastructure investments.
The increasing burden of cancer is expected to stimulate the growth of the histology equipment market. Cancer is characterized by the abnormal growth and spread of cells, which can be fatal if not treated. The rising number of cancer cases is driven by both lifestyle factors and genetic and demographic factors. Histology equipment is essential for diagnosing and studying cancer by enabling detailed tissue examination, which helps identify cancer types and stages. In 2022, the American Cancer Society estimated 609,360 cancer deaths in the U.S., with the number projected to increase slightly in 2023. Hence, the growing cancer burden is driving the histology equipment market.
The histology and cytology market covered in this report is segmented –
1) By Product: Instruments And Analysis Software System, Consumable And Reagents
2) By Test Type: Microscopy Methods, Flow Cytometry, Molecular Genetic Methods
3) By Application: Drug Discovery And Designing, Clinical Diagnostics, Academic Research
4) By End User: Pharma And Biotech Companies, Contract Development And Manufacturing Organizations (CDMO), Diagnostic Laboratories, Other End Users
Subsegments:
1) By Instruments And Analysis Software System: Microtomes, Tissue Processors, Stainers, Coverslippers, Cytology Slide Preparation Instruments, Digital Imaging Systems, Histology And Cytology Analysis Software
2) By Consumables And Reagents: Staining Reagents, Fixatives, Embedding Media, Antibodies, Cytology Collection Kits, Histology Slides
Leading firms in the histology and cytology market are concentrating on the development of advanced technologies, like high-speed cell imaging, to maintain their market standing. This method captures swift cellular operations with high temporal acuity, crucial for examining dynamic activities such as cell division, intracellular transport, signaling movements, and the interaction between cells and their environment. For example, in June 2022, Becton, Dickinson, and Company, a medical device enterprise based in the US, introduced a novel cell sorting device having two groundbreaking technologies, enabling scientists to gather more specific cell information that was unattainable with traditional flow cytometry tests. This revolutionary device merges spectral identification with high-speed imaging, facilitating real-time examination of various cell traits. It boosts accuracy by identifying minor distinctions in cellular features like fluorescence intensity and emission spectrums, which is vital for properly categorizing varied cell groups. This significant advancement is set to expedite biomedical findings, promote cell-oriented therapies, and facilitate personalized medicine by offering unparalleled understanding into complicated cellular actions and relationships in an extraordinary manner.
Major companies operating in the histology and cytology market are:
• Thermo Fisher Scientific Inc.
• Roche Diagnostics International Ltd.
• Agilent Technologies Inc.
• Hologic Inc.
• Leica Microsystems Nussloch GmbH
• Cole-Parmer Instrument Company LLC
• Sakura Finetechnical Company Ltd.
• Biogenex Laboratories Inc.
• StatLab Medical Products Inc.
• Biocare Medical LLC
• Andwin Scientific
• A. Menarini Diagnostics S.r.l
• Milestone Medical Inc.
• Diapath S.p.A.
• PolyScience Inc.
• CellPath USA
• Medite Medical GmbH
• Histo-Line Laboratories s.r.l.
• Hacker Instruments & Industries Inc.
• Amos Scientific Pty. Ltd.
• TissueGnostics GmbH
• Konfoong Bioinformation Tech Co. Ltd.
• Labstac USA
• Intelsint Srl
North America was the largest region in the histology and cytology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the histology and cytology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.